These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 22615103

  • 21. Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2014 Sep; 89(9):915-25. PubMed ID: 25124313
    [Abstract] [Full Text] [Related]

  • 22. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.
    Bacher U, Haferlach T, Schnittger S, Kreipe H, Kröger N.
    Br J Haematol; 2011 Apr; 153(2):149-67. PubMed ID: 21401573
    [Abstract] [Full Text] [Related]

  • 23. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
    Singh ZN, Post GR, Kiwan E, Maddox AM.
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
    [Abstract] [Full Text] [Related]

  • 24. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

  • 25. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
    Chen B, Ma Y, Xu X, Wang X, Qin W, Ji M, Lin G.
    Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
    [Abstract] [Full Text] [Related]

  • 26. Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome.
    Kantarjian HM, O'Brien S, Shan J, Aribi A, Garcia-Manero G, Jabbour E, Ravandi F, Cortes J, Davisson J, Issa JP.
    Cancer; 2007 Jan 15; 109(2):265-73. PubMed ID: 17133405
    [Abstract] [Full Text] [Related]

  • 27. Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment.
    Yi JH, Huh J, Kim HJ, Kim SH, Kim SH, Kim KH, Do YR, Mun YC, Kim H, Kim MK, Kim HJ, Kim T, Kim DD.
    Ann Hematol; 2013 Apr 15; 92(4):459-69. PubMed ID: 23262795
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA, Comes AM, Vizcarra E, Benet I, Arbona C, Prósper F, Solano C, García Clavel B, Marugán I, Lluch A, García-Conde J.
    Bone Marrow Transplant; 2000 Jun 15; 25(11):1203-8. PubMed ID: 10849534
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management.
    Garcia-Manero G.
    Am J Hematol; 2011 Jun 15; 86(6):490-8. PubMed ID: 21594886
    [Abstract] [Full Text] [Related]

  • 35. The clinical management of chronic myelomonocytic leukemia.
    Padron E, Komrokji R, List AF.
    Clin Adv Hematol Oncol; 2014 Mar 15; 12(3):172-8. PubMed ID: 24927265
    [Abstract] [Full Text] [Related]

  • 36. [Chronic myelomonocytic leukemia: from diagnosis to treatment].
    Hafraoui K, De Prijck B, Beguin Y.
    Rev Med Suisse; 2013 Aug 28; 9(395):1512, 1514-7. PubMed ID: 24024420
    [Abstract] [Full Text] [Related]

  • 37. Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia.
    Hunter AM, Zhang L, Padron E.
    Curr Treat Options Oncol; 2018 Oct 27; 19(12):67. PubMed ID: 30367269
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.